We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Hip Resurfacing System Eases Arthritis Pain

By HospiMedica staff writers
Posted on 04 Sep 2007
A new hip arthroplasty resurfacing system is intended for reduction or relief of pain and/or improved hip function in patients with non-inflammatory degenerative arthritis or inflammatory arthritis.

The Cormet Hip Resurfacing system is a metal-on-metal resurfacing artificial hip replacement system, surgically implanted to replace a hip joint. More...
The system relieves hip pain and improves hip function by replacing parts of the hip joint that have been severely damaged by degenerative joint diseases such as osteoarthritis, rheumatoid arthritis, traumatic arthritis, dysplasia, or avascular necrosis. The system is intended for patients who, due to their relatively younger age or increased activity level, may not be suitable for traditional total hip replacement due to an increased possibility of future hip joint revision.

The system has two parts: an acetabular component--a socket in the shape of a shallow cup--and a femoral resurfacing component in the form of a ball head. During the procedure, the acetabular component replaces the damaged surface of the hip socket, while the femoral resurfacing component covers the femoral head. The components, made from highly polished metal, articulate within each other, forming a coupled bearing. The Cormet Hip Resurfacing system is manufactured by Corin (Cirencester, UK). The U.S. Food and Drug Administration (FDA) orthopedic and rehabilitation devices panel voted in favor of Corin's premarket approval application (PMA).

"We pioneered metal-on-metal resurfacing technology in the late 1980s, and our Cormet device has been sold and successfully implanted around the world for almost a decade,” said Ian Paling, Corin's CEO. "We are very confident that the opportunities for Cormet in the U.S. are substantial, as all our market research points to significant demand for this hip resurfacing technology, which is especially attractive to the younger, active ‘baby-boomer' generation.”


Related Links:
Corin

New
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Gold Member
12-Channel ECG
CM1200B
New
Patient Monitoring System
AlarmSense
New
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Health IT

view channel
Photo courtesy of Adobe Stock

Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings

Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.